By Professor Michelle Anne Farrar

Reports

Kariyawasam D; Farrar M; Meagher C; Heather N; Bhattacharya K; Sampaio H; Cini J; Masi E; Burrows L; Greenslade M; Heller R; Allcock R; Divanisova S; Carrivick S; Kay A; Siu C; Webster D; Ranieri E; Moore F; Crisp G; Pitt J; Greed L; De Hora M; Greaves R; Wotton T; Wilgen U; Wiley V; Cairns A; Clark D; Yiu E; O'Grady G; Kava M; Ware T; Miller C; Tolich F; Wedlake C, 2025, A Guideline for Newborn Screening in Spinal Muscular Atrophy in Australia and Aotearoa New Zealand, University of New South Wales, http://dx.doi.org/10.26190/unsworks/31305, https://www.unsw.edu.au/content/dam/images/medicine-health/clinical-medicine/research/2025-05-nbs-for-sma/2025-05-nba-for-sma-guideline-280525.pdf

Shih S; Farrar M; Veronica W; Wong M; Keller E; Chambers G, 2021, Economic evaluation of newborn screening for severe combined immunodeficiency (SCID) and spinal muscular atrophy (SMA). Sydney: National Perinatal Epidemiology and Statistics Unit, the University of New South Wales, Sydney.

Back to profile page